Suppr超能文献

在体外胎盘灌注模型中利托那韦与齐多夫定的胎盘转运。

Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model.

作者信息

Casey B M, Bawdon R E

机构信息

Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235-9032, USA.

出版信息

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):758-61. doi: 10.1016/s0002-9378(98)70078-x.

Abstract

OBJECTIVE

The object was to determine the placental transfer of ritonavir alone and in combination with zidovudine.

STUDY DESIGN

Twelve placental perfusion studies were performed at trough (1-2 microg/mL) and peak (approximately 20 microg/mL) combinations of ritonavir and zidovudine. Accumulation of ritonavir was determined.

RESULTS

Transfer of ritonavir at trough concentrations was undetectable (<0.025 microg/mL). The clearance index of ritonavir at peak concentration was 0.085 +/- 0.05 and was unaffected by zidovudine. The fetal concentration of ritonavir was 0.0758 +/- 0.22 microg/mL at a maternal concentration of approximately 20 microg/mL and 25.5 +/- 6.9 microg/mL at a concentration of 100 microg/mL. There was no tissue accumulation of ritonavir either alone or with zidovudine.

CONCLUSION

The clearance index of ritonavir at therapeutic levels was extremely low, with little accumulation in the fetal compartment and no accumulation in placental tissue. Zidovudine does not significantly affect the transfer or accumulation of ritonavir.

摘要

目的

本研究旨在确定单独使用利托那韦以及利托那韦与齐多夫定联合使用时的胎盘转运情况。

研究设计

在利托那韦与齐多夫定的谷浓度(1 - 2微克/毫升)和峰浓度(约20微克/毫升)组合下进行了12项胎盘灌注研究。测定了利托那韦的蓄积情况。

结果

谷浓度下利托那韦的转运无法检测到(<0.025微克/毫升)。峰浓度下利托那韦的清除指数为0.085±0.05,且不受齐多夫定影响。母体浓度约为20微克/毫升时,胎儿体内利托那韦浓度为0.0758±0.22微克/毫升;母体浓度为100微克/毫升时,胎儿体内利托那韦浓度为25.5±6.9微克/毫升。单独使用或与齐多夫定联合使用时,利托那韦均无组织蓄积。

结论

治疗水平下利托那韦的清除指数极低,在胎儿组织中蓄积极少,在胎盘组织中无蓄积。齐多夫定对利托那韦的转运或蓄积无显著影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验